Intuitive Surgical, Inc. which can be found using ticker (ISRG) now have 25 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $512.00 and $375.00 and has a mean share price target at $436.09. (at the time of writing). Now with the previous closing price of $444.74 this would imply there is a potential downside of -1.9%. The 50 day moving average now sits at $412.73 and the 200 moving average now moves to $359.57. The market capitalization for the company is 157.31B. The current share price for the company is: $443.50 USD
The potential market cap would be $154,252,454,292 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 80.05, revenue per share of $20.79 and a 8% return on assets.
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company’s products and related services enable physicians and healthcare providers to access minimally invasive care. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and instruments and accessories. Its da Vinci products consist of five categories, such as da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a suite of systems, learning, and services offerings. Its Ion endoluminal system extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Its services include readiness support, maintenance support, perioperative consulting, customer hospital analytics, and market consulting optimization.
